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Abstarct 
    "Thalassemias": are forms of inherited recessive blood disorder that originated in 
the Mediterranean region. In" thalassemia", the disease is caused by the excessive 
destruction or degradation of red blood cells due to formation of abnormal 
hemoglobin molecules, because of a defect through a genetic mutation or deletion. 
The aim of this study to assess distribution of “thalassemia’s" patients according to  
age, sex, area and types of disease in Baghdad city. This study concluded that higher 
percentage of Intermediate (32.6%) among age groups (<1-4.9). Age groups and type 
of "Thalassemia" showed highly significantly different. The highest percentage of 
male cases had Intermediate (32.6%), While the highest percentage of male cases had 
Major (20.4%). No significant difference between sex and type of “Thalassemia". 
Finally the study recommended earlier examination before marriage and examination 
for pregnant women, and health program of community about "Thalassemia". 
Introduction:     
    
 " Thalassemia’s":( are forms of inherited recessive blood disorder that originated 
in the Mediterranean region. This disease was caused by the excessive destruction 
or degradation of red blood cells due to formation of abnormal hemoglobin 
molecules, because of a defect through a genetic mutation or deletion [1]. From the 
Greek  thalassa ("sea") and -emia ("blood"). The etymology indicates the 
epidemiology of the disorder in that it commonly occurs in patients of 
Mediterranean descent. The term was first used in 1932 [2]. The etymology indicates 
the epidemiology of the disorder in that it commonly occurs in patients such as 
India and Pakistan are seeing a large increase " thalassemia" patients due to lack of 
genetic counseling and screening. There is growing concern that "thalassemia" may 
become a very serious problem in the next 50 years, one that will burden the world's 
blood bank supplies and the health system in general. There are an estimated 1,000 
people living with" thalassemia" major in the United States and an unknown 
number of carriers [3]  [4]. In Europe, the highest concentrations of the disease are 
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found in Greece, coastal regions in Turkey (particularly the Aegean Region such as 
Izmir, Balikesir, Aydin, Mugla, and Mediterranean Region such as Antalya, Adana, 
Mersin), in parts of Italy, particularly Southern Italy and the lower Po valley [5].  
 
      The major Mediterranean islands (except the Balearics) such as Sicily, Sardinia, 
Malta, Corsica, Cyprus, and Crete are heavily affected in particular. Other 
Mediterranean people, as well as those in the vicinity of the Mediterranean, also 
have high rates of "thalassemia" including people from West Asia and North Africa. 
Far from the Mediterranean, South Asians are also affected, with the world's highest 
concentration of carriers (16% of the population) being in the Maldives [6].  
 
   The classifications of "Thalassemia’s" are according to which chain of the 
hemoglobin molecule is affected. In" α thalassemia’s", production of the α globin 
chain is affected, while in" β thalassemia" production of the β globin chain is 
affected[7].  
 
        "Thalassemia" has an autosomal recessive pattern of inheritance both "α and β 
thalassemia’s" are often inherited in an autosomal recessive fashion, although this is 
not always the case. Cases of dominantly inherited "α and β thalassemia’s" have 
been reported, the first of which was in an Irish family with two deletions of 4 and 11 
bp in exon 3 interrupted by an insertion of 5 bp in the β-globin gene. For the 
autosomal recessive forms of the disease, both parents must be carriers in order for 
a child to be affected [3]. 
  
           "Mild thalassemia ": patients with "thalassemia" traits do not require medical 
or follow-up care after the initial diagnosis is made [8]. Patients with "β-thalassemia 
trait" should be warned that their condition can be misdiagnosed for the common 
Iron deficiency anemia. They should eschew empirical use of Iron therapy; yet iron 
deficiency can develop during pregnancy or from chronic bleeding [9]. Counseling is 
indicated in all persons with genetic disorders, especially when the family is at risk 
of a severe form of disease that may be prevented [10].  
 
       " Severe thalassemia" : Patients with "severe thalassemia" require medical 
treatment and a blood transfusion regimen was the first measure effective in 
prolonging life [8]. 
 
     A screening policy exists in Cyprus to reduce the incidence of" thalassemia", 
which since the program's implementation in the 1970s (which also includes pre-
natal screening and abortion) has reduced the number of children born with the 
hereditary blood disease from 1 out of every 158 births to almost zero [11].  
    It was invented in 2002 by Dr. PietroSodani. The results are: "thalassemia "free 
survival rate 70%, rejection 23% and mortality 7%. The best results are with very 
young patients[12].  
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    The aim of study:  was identify the prevalence of " thalassemia’s" patients 
according to age ,sex, area and  types of disease in Baghdad   city. 
   Materials of methods:   A descriptive Cross- sectional study is carried to 
identify the prevalence of" thalassemia’s". Data taken from the medical records of 
"thalassemia’s" cases whom attending to" Ibn- al-Baldi " hospital in Baghdad city. 
Purposive (non-  probability) of 500 cases of" thalassemia" were included in present 
study . 
 Statistical analysis: For presentation data and analysis using SPSS Vr.18.Using 
chi-square  and Mont Carlo tests (MCP )at 5% &1% level of significant. 
   
  Results  
           In table(1) cases showed higher percentage of Intermediate (32.6%) among age 
groups  
(<1-4.9)year , compared to Major higher percentage was(17.0%) among age groups  (5-
9.9)year, 
 the association ,between  age groups(year)and type of "Thalassemia" showed highly 
significantly different . 
 
Table (1): Distribution of Cases by age group(year) and type of 
"Thalassemia" 
Age group(year) 
Type of "Thalassemia" 
Total Major Intermediate 
 (<1-4.9) No.  31 163 194 
%  6.2% 32.6% 38.8% 
(5-9.9) No.  85 114 199 
%  17.0% 22.8% 39.8% 
 (10-14.9) No.  28 24 52 
%  5.6% 4.8% 10.4% 
(15-24.9) No.  15 5 20 
%  3.0% 1.0% 4.0% 
 (25-34.9) No.  14 7 21 
%  2.8% 1.4% 4.2% 
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(35-45) No.  12 2 14 
%  2.4% 0.4% 2.8% 
Total No.  185 315 500 
%  37.0% 63.0% 100.0% 
MCP< 0.01 (HS)  
      Table(2): represents the distribution of "Thalassemia" cases by types and sex. The 
highest percentage of male cases had Intermediate (32.6%), While the highest percentage of 
male cases had Major (20.4%). No significant difference between sex and type of 
"Thalassemia'. 
 
Table(2):Distribution of Cases by sex and type of "Thalassemia" 
Sex 
Type of "Thalassemia" 
Total 
Major Intermediate 
No. % No. % 
 Male   102 20.4% 163 32.6% 265 53.0% 
 Female   83 16.6% 152 30.4% 235 47.0% 
Total   185 37.0% 315 63.0% 500 100.0% 
X2=0.537       P>0.05  (NS)   
       Table(3):represents the distribution of "Thalassemia" cases by types and address. 
The highest percentage of cases had Intermediate (60.6%)  from  Baghdad and the 
lowest percentage had Major (1.8%)from Others governorates. No significant 
difference between address and type of "Thalassemia". 
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Table(3):Distribution of Cases by address and type of "Thalassemia" 
Address 
Type of "Thalassemia" 
Total 
Major 
Intermedia
te 
No. % No. % 
 Baghdad   176 35.2% 303 60.6
% 
479 95.8% 
Others governorates   9 1.8% 12 2.4% 21 4.2% 
Total   185 37.0
% 
315 63.0
% 
500 100.0% 
    X2=0.323       P>0.05    (NS) 
    Table(4):represents the distribution of "Thalassemia" cases by types and Year of 
infections. The highest percentage of cases had Intermediate (12.4%)  at year2010  
and the lowest percentage (0.6%)at year 2006 .On another hand the highest 
percentage of cases had Major (8.8%) at 2010 and the lowest percentage (0.2%) 
at2001. Highly significant difference between the type of "Thalassemia" and year of 
infections.     
Table(4):Distribution of Cases by year of infections and type of 
"Thalassemia"  
 
Year of infections 
Type of "Thalassemia"  
Total Major Intermediate 
No. % No. % No. % 
(2001 – 2004) 13 2.6% 31 6.2% 44 8.8% 
(2005 – 2008) 56 11.2% 104 20.8% 160 32.0% 
(2009 – 2012) 116 23.2
% 
180 36.0% 296 59.2% 
Total 185 37.0
% 
315 63.0% 500 100.0% 
MCP< 0.01 (HS) 
      Table(5):represents the distribution of "Thalassemia" cases by types and Duration 
of disease. The highest percentage of cases was intermediate (17.0%) had (<1-
1.9)year  duration of disease and also the  highest percentage of cases was  Major 
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(10.6%)had (<1-1.9)year  duration of disease. No significant difference between the 
type of "Thalassemia" and duration of disease . 
 
Table(5):Distribution of Cases by duration of disease and type of 
"Thalassemia" 
 
Duration of 
disease(Years)  
Type of "Thalassemia"  
Total Major Intermediate 
No. % No. % No. % 
(<1-1.9) 53 10.6% 85 17.0% 138 27.6% 
(2-2.9) 42 8.4% 58 11.6% 100 20.0% 
(3-3.9) 23 4.6% 43 8.6% 66 13.2% 
(4-4.9) 27 5.4% 51 10.2% 78 15.6% 
(5-5.9) 19 3.8% 29 5.8% 48 9.6% 
(6-8+) 21 4.2% 49 9.8% 70 14.0% 
Total 185 37.0% 315 63.0% 500 100.0% 
X2=4.456       P>0.05  (NS)   
     In table(6) cases showed higher percentage of Intermediate (47.0%) had no family 
history, so cases of Major showed a higher percentage (28.0%)had no family history, 
the association between  family history and type of "Thalassemia" was non 
significantly different . 
 
Table(6):Distribution of  Cases by family history and type of 
"Thalassemia" 
 
Family History  
 
 
Type of "Thalassemia" 
 
Total 
 Major Intermediate 
No. % No. % No. % 
NO 140 28.0% 235 47.0% 375 75.0% 
Yes 45 9.0% 80 16.0% 125 25.0% 
Total 185 37.0% 315 63.0% 500 100% 
 
X2=0.072       P>0.05  (NS)  
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DISCUSSION  
        Generally, "thalassemia’s" are prevalent in populations that evolved in humid 
climates where malaria was endemic. It affects all races, as "thalassemia’s" protected 
these people from malaria due to the blood cells' easy degradation[13].  
     The researchers agreed that "Thalassemia". The results of this study indicated that; 
demographic data ( gender, age,  and address) . 
The present study showed the age groups and type of "Thalassemia" was associated by 
highly statistically significant this agreed  with the study carried  out in Malaysia[14].  
      The present study showed the highest percentage of" Thalassemia" was among male 
cases this disagreement with study done in Indian which found female cases higher 
male cases[15].  
 
      In  present study it was  "Mild thalassemia ": patients with "thalassemia" traits do 
not require medical or follow-up care after the initial diagnosis is made[8].  Patients 
with" β-thalassemia" trait should be warned that their condition can be misdiagnosed 
for the "common Iron "deficiency anemia. They should eschew empirical use of Iron 
therapy; yet iron deficiency can develop during pregnancy or from chronic bleeding 
[9]. Counseling is indicated in all persons with genetic disorders, especially when the 
family is at risk of a severe form of disease that may be prevented [10]. Severe 
"thalassemia": Patients with severe "thalassemia "require medical treatment and a 
blood transfusion regimen was the first measure effective in prolonging life [8].  
 found the highest percentage of cases from  Baghdad(urban), this agreement with the 
study from  Malays, Chinese and Indians cases  of "Thalassemia" [16].  
     Non-significant difference between the type of "Thalassemia" and duration of   
disease this disagreement with the study carry out in Malaysia [17].  
 
          The cases showed higher percentage of Intermediate (47.0%) had not family 
history. The association between  family history and type of "Thalassemia" was non 
significantly difference , in study done by Vanichsetakul in2010 about Genetic 
counseling found  "Thalassemia’s" and abnormal hemoglobin genes can be inherited 
from symptom-free parents, if both of parents are correspond-gene carriers [18].  
 
          In Iran as a premarital screening, the man's red cell indices are checked first, if he 
has microcytosis (mean cell hemoglobin< 27 pg or mean red cell volume< 80 fl), the 
woman is tested. When both are microcytic their hemoglobin A2 concentrations are 
measured. If both have a concentration above 3.5% (diagnostic of" thalassemia trait") 
they are referred to the local designated health post for genetic counseling [19]  
 
       The major Mediterranean islands (except the Balearics) such as Sicily, Sardinia, 
Malta, Corsica, Cyprus, and Crete are heavily affected in particular. Other 
Mediterranean people, as well as those in the vicinity of the Mediterranean, also have 
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high rates of" thalassemia", including people from West Asia and North Africa. Far 
from the Mediterranean, South Asians are also affected, with the world's highest 
concentration of carriers (16% of the population) being in the Maldives [6].  
 
Conclusions 
       - The cases showed higher percentage of Intermediate (32.6%) among age  groups   (<1-
4.9). Age groups and type of "Thalassemia" showed highly significantly difference. 
 -The highest percentage of male cases had Intermediate (32.6%), while the highest   
percentage of male cases had Major (20.4%). No significant difference between sex and 
type of  "Thalassemia". 
 - The highest percentage of cases had Intermediate (60.6%) from  Baghdad. No 
significant   difference between address and type of "Thalassemia".  
  -The highest percentage of cases had Intermediate (12.4%) at year2010 and the    
lowest         percentage (0.6%)at year 2006 . Highly significant difference between the 
type of "Thalassemia" and year of infections. 
          -The highest percentage of cases was intermediate (17.0%) had (<1-1.9) year   duration 
of disease. No significant difference between the type of "Thalassemia" and duration of 
disease. 
          -The cases showed higher percentage of Intermediate (47.0%) had not family history. 
The   association between  family history and type of "Thalassemia" was non 
significantly difference . 
  Recommendations 
1- Earlier examination before the marriage and examination for pregnant women.     
2-Health program of community about "Thalassemia". 
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